mTOR inhibitors: A novel class of anti-cancer agents
-
* Corresponding author: Syed A Hussain syedanashussain.91@gmail.com
Infectious Agents and Cancer 2012, 7:1 doi:10.1186/1750-9378-7-1
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 19 Aug 2011 | |
| Reviewer's Report | Ryan Dowling | 16 Sep 2011 | |
| Reviewer's Report | David Teachey | 06 Oct 2011 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 20 Nov 2011 |
| Reviewer's Report | Ryan Dowling | 01 Dec 2011 | |
| Reviewer's Report | David Teachey | 07 Dec 2011 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 16 Dec 2011 |
| Editorial acceptance | 19 Dec 2011 | ||
| Published | 03 Jan 2012 |